News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
Sexually transmitted infections tests and treatment
PrEP services could enhance STI control, says World Health Organization

The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better

Published
22 July 2019
By
Roger Pebody
People who inject drugs
PrEP Education Campaigns Leave People Who Inject Drugs Behind

On July 12, the Centers for Disease Control and Prevention published a report that found an “encouraging” increase in recent years in urban-living queer men’s awareness of pre-exposure prophylaxis (PrEP). But in some of the cities covered by the CDC’s report, many people who inject drugs are wholly unaware of the “miracle drug,” as HIV activists have dubbed it.

Published
21 July 2019
From
Filter
PrEP programmes and uptake
No new cases of HIV among people in Wales taking PrEP

Vaughan Gething, the Welsh minister for health and social services, said he was “delighted” that access to PrEP was now “fully embedded” into sexual health services.

Published
21 July 2019
From
The Pharmaceutical Journal
PrEP programmes and uptake
New Algorithms Could Help Providers ID PrEP Candidates

Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.

Published
17 July 2019
From
Poz
PrEP programmes and uptake
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users

Yale University investigators are leading a trial that is testing a bio-behavioral intervention’s ability to improve pre-exposure prophylaxis (PrEP) adherence and reduce the risk of HIV acquisition in individuals with opioid dependency, a population experiencing new outbreaks of HIV.

Published
15 July 2019
From
Contagion Live
PrEP programmes and uptake
How Australia Could Almost Eradicate H.I.V. Transmissions

It took universal health care, political will and a health campaign designed to terrify the public, but nearly four decades into the H.I.V. crisis, Australian researchers say the country is on a path toward making transmissions of the virus vanishingly rare.

Published
12 July 2019
From
New York Times
PrEP programmes and uptake
Australian gay and bisexual men interested in switching to on-demand PrEP

Half of gay and bisexual men using PrEP in Australia would be interested in switching from taking daily PrEP to taking on-demand PrEP, and this interest was

Published
11 July 2019
By
Unity Sandasi
PrEP programmes and uptake
PrEP Trials Offer Insight for Reaching at-Risk Women in Sub-Saharan Africa

Reaching individuals at high risk of acquiring HIV infection continues to pose a challenge to uptake of HIV pre-exposure prophylaxis (PrEP). A new study looked at PrEP clinical trials in sub-Saharan Africa, examining recruitment strategies to reach women at high risk of contracting HIV.

Published
10 July 2019
From
Contagion Live
PrEP programmes and uptake
Same-day PrEP initiation a favorable option for patients at risk for HIV

Same-day initiation of pre-exposure prophylaxis, or PrEP, for HIV prevention was found to be safe, feasible and well-received among patients at a walk-in STD clinic, according to a recently published study. During the study, which was conducted at a clinic in Denver, a high proportion of the participants were linked to ongoing PrEP care, researchers reported.

Published
10 July 2019
From
Healio
Pharmaceutical industry
What Does PrEP Cost Outside the United States?

For the past several years, doctors in the United States have watched enviously as other countries have approved generic versions of PrEP made by Mylan, Teva, and other generic drug companies. These cheaper generics have made it easier for governments to support large PrEP scale-up programs.

Published
04 July 2019
From
The Body
← First12345...16Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.